Labguru and Titian Software rebrand as Cenevo

Aug. 8, 2025
2 min read

Titian Software and Labguru have rebranded as Cenevo, bringing together the two companies’ solutions, Labguru and Mosaic, under a new, unified brand, to enable further innovation and increased collaboration to accelerate scientific discovery.

The combined organization specializes in lab management systems, automation, orchestration, data management and AI technology.

Cenevo software enables smart connected labs that are automated, data-centric and AI enabled, by combining Mosaic’s sample-centric lab operations with Labguru’s experimental-centric inventory, registration, ELN and LIMS technology.

The Cenevo name – derived from “central” and “evolution” – underscores the company's central role in accelerating the next evolution of scientific research.

Cenevo’s recent research shows that only 15% of labs are fully digitalized, while 50% still rely heavily on manual processes. Within the next two years, 45% of the 150+ labs surveyed intend to implement next-generation lab technologies such as AI and advanced robotics. These insights fuel the company’s strategy and product development, reinforcing Cenevo’s commitment to innovation and its mission to help labs overcome industry challenges such as data overload, funding pressures, and manual process inefficiencies and errors.

Mosaic software offers a comprehensive suite of tools to maximize the efficiency and accuracy of sample tracking, management, and workflow automation across modalities – with over 150 device and system integrations to maximize efficiency, orchestration and accuracy. Labguru software provides a cloud-based multimodal laboratory data management research-to-production platform, combining ELN, LIMS, registry, inventory management and AI-based informatics tools – scientists utilize Labguru to plan, document, track, streamline, automate, and share their scientific research encompassing the full life cycle from research to production.

Under the leadership of CEO Keith Hale, the company is guided by a seasoned executive team with deep expertise across biopharma, biotech, AI, and digital transformation. This experienced group brings decades of success across both scientific discovery and technology innovation.

Cenevo is backed by Battery Ventures, a global technology-focused investment firm with deep domain expertise in life science informatics and laboratory automation. Titian received a significant investment from Battery in June 2022, with Labguru joining the group in April 2024.

Read the full announcement at Cenevo

About the Author

Sign up for Medical Laboratory Observer eNewsletters